Proficio Capital Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Proficio Capital Partners's MRNA Position: Q3 2026 in Review
Proficio Capital Partners reduced its Moderna (MRNA) stake by 27% in Q3 2026, selling an estimated $124K and leaving 3,102 shares worth $597K. The position accounts for 0.02% of the portfolio, ranked #199.
Proficio Capital Partners first reported a position in MRNA in Q2 2019 and has held it in 11 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Proficio Capital Partners held 3,102 shares of Moderna worth $597K as of Q3 2026.
- Proficio Capital Partners sold 1,149 Moderna shares in Q3 2026, an estimated $124K.
- Moderna made up 0.02% of Proficio Capital Partners's portfolio in Q3 2026, its #199 holding.
- Proficio Capital Partners first reported a position in Moderna in Q2 2019 and has held it in 11 quarters since.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Proficio Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.